Psoriasis

Blog

Blog Archivi | BioBlog

Health

Health Archivi | BioBlog

Medical biotechnology

Medical biotechnology Archivi | BioBlog

Medicines

Medicines Archivi | BioBlog

Dermatology

Dermatology Archivi | BioBlog

Health Dermatology Psoriasis Woman

Health Dermatology Psoriasis Woman Archivi | BioBlog

leather

leather Archivi | BioBlog

Psoriasis Archivi | BioBlog

Marketing

Marketing, Autore presso BioBlog

BioBlog

The arrival of spring is not good news for psoriatics because in the heat you have to wear light clothes which inevitably reveal your arms and legs. Psoriasis is the most diagnosed skin disease by dermatologists, which not only &quot;marks&quot; the skin, but also the soul. In fact, many patients feel uncomfortable because of the&hellip; Continua a leggere Psoriasis: it can be controlled

Psoriasis: it can be controlled | BioBlog

https://secure.gravatar.com/avatar/6aa85827a3239734c6bdf355c7c1cc3cd9f9857592327e16f7f85b8fd3e37eaa?s=96&d=mm&r=g

Genetics (DNA)

Genetics (DNA) Archivi | BioBlog

News in pills from the world

News in pills from the world Archivi | BioBlog

Pathologies

Pathologies Archivi | BioBlog

causes psoriasis

causes psoriasis Archivi | BioBlog

Health Dermatology Psoriasis Man

Health Dermatology Psoriasis Man Archivi | BioBlog

world psoriasis day

world psoriasis day Archivi | BioBlog

Two and a half million Italians suffer from psoriasis , a non-contagious skin disease which, however, is often a cause of shame for the sick. The pathology initially manifests itself with reddish patches that are covered with &quot;scales&quot; and whitish growths . The disease has alternating phases: it passes from the chronic sentence to that&hellip; Continua a leggere World psoriasis day

World psoriasis day | BioBlog

Dermatitis

Dermatitis Archivi | BioBlog

Health Dermatology Dermatitis Woman

Health Dermatology Dermatitis Woman Archivi | BioBlog

A drug, still under study by Johnson &amp; Johnson shows positive effects that bode well against psoriasis , one of the most common forms of chronic dermatitis in the world. The news reported from a phase 3 study of Ustekinumab (CNTO 1275) shows a significant reduction, quantified around 75% (data obtained by measuring the affected&hellip; Continua a leggere Monoclonal antibodies against psoriasis

Monoclonal antibodies against psoriasis | BioBlog

Home